Patent directory · USPTO A61K / A61P
Patents matching “VACCINEX, INC.”
41 pharma patents match "VACCINEX, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 41 pharmaceutical patents matching "VACCINEX, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12201719
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
granted -
US 12070500
Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis
granted -
US 12006365
Human anti-semaphorin 4D antibody
granted -
US 12006364
Anti-CD100 antibodies and methods for using the same
granted -
US 11981730
Anti-CXCL13 antibodies and methods of using the same
granted -
US 11859000
Anti-CCR8 antibodies and uses thereof
granted -
US 11660330
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
granted -
US 11597765
Use of semaphorin-4D binding molecules for the treatment of Rett syndrome
granted -
US 11572408
Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent
granted -
US 11534488
Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability
granted -
US 11427634
Human anti-semaphorin 4D antibody
granted -
US 11274149
Anti-CD100 antibodies and methods for using the same
granted -
US 11078295
Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases
granted -
US 10829550
Polynucleotides encoding anti-CXCL13 antibodies
granted -
US 10800853
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted -
US 10526414
Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases
granted -
US 10494440
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke
granted -
US 10385136
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted -
US 10301393
Methods of treating multiple sclerosis using anti-CD20 antibodies
granted -
US 10111950
Modified glycolipids and methods of making and using the same
granted -
US 9963504
Anti-CXCL13 antibodies and methods of using the same
granted -
US 9890213
Methods for the treatment of B cell-mediated inflammatory diseases
granted -
US 9828435
Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency
granted -
US 9790271
Methods for increasing immunoglobulin A levels
granted